SCGB3A2 and cancer: Immunofluorescence analysis revealed that all seven of the SCGB3A2-susceptible human cancer cells expressed SDC1 on their cell surfaces (Fig. 2B for H596, H358, SW620, and H157 and Supplementary Fig. S1D, F, K for H322, A549, and HCT116, white arrowheads).